TreeWAS – Variant ID: rs2281597

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z13.9 Special screening examination, unspecified	0.000	0.943	0.057
R01.1 Cardiac murmur, unspecified	0.015	0.985	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.000	0.989	0.011
T42.4 Benzodiazepines	0.011	0.989	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.011	0.989	0.000
C01 Malignant neoplasm of base of tongue	0.000	0.989	0.011
C02.1 Border of tongue	0.000	0.989	0.011
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.011	0.989	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.000	0.990	0.010
C02.2 Ventral surface of tongue	0.000	0.990	0.010
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.010	0.990	0.000
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.010	0.990	0.000
C02.9 Tongue, unspecified	0.000	0.990	0.010
Z13.0 Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.991	0.009
T42.1 Iminostilbenes	0.009	0.991	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.009	0.991	0.000
Z13 Special screening examination for other diseases and disorders	0.000	0.991	0.009
C06 Malignant neoplasm of other and unspecified parts of mouth	0.000	0.991	0.009
Z92.4 Personal history of major surgery, not elsewhere classified	0.000	0.991	0.009
T42.0 Hydantoin derivatives	0.008	0.991	0.000
T42.3 Barbiturates	0.008	0.991	0.000
C02.8 Overlapping lesion of tongue	0.000	0.992	0.008
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.008	0.992	0.000
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)	0.008	0.992	0.000
C02.0 Dorsal surface of tongue	0.000	0.992	0.008
C09 Malignant neoplasm of tonsil	0.000	0.992	0.008
C03 Malignant neoplasm of gum	0.000	0.992	0.008
T42.5 Mixed antiepileptics, not elsewhere classified	0.008	0.992	0.000
T42.2 Succinimides and oxazolidinediones	0.008	0.992	0.000
Z43.1 Attention to gastrostomy	0.000	0.992	0.008
C12 Malignant neoplasm of pyriform sinus	0.000	0.992	0.008
C02.3 Anterior two-thirds of tongue, part unspecified	0.000	0.992	0.008
C07 Malignant neoplasm of parotid gland	0.000	0.992	0.008
T36-T50 Poisoning by drugs, medicaments and biological substances	0.008	0.992	0.000
C04 Malignant neoplasm of floor of mouth	0.000	0.992	0.008
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.008	0.992	0.000
C13 Malignant neoplasm of hypopharynx	0.000	0.992	0.008
C02.4 Lingual tonsil	0.000	0.992	0.008
C10 Malignant neoplasm of oropharynx	0.000	0.992	0.008
F29 Unspecified nonorganic psychosis	0.008	0.992	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.000	0.992	0.007
C00 Malignant neoplasm of lip	0.000	0.992	0.007
C06.9 Mouth, unspecified	0.000	0.993	0.007
C34.1 Upper lobe, bronchus or lung	0.000	0.993	0.007
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.000	0.993	0.007
C06.2 Retromolar area	0.000	0.993	0.007
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.007	0.993	0.000
C09.1 Tonsillar pillar (anterior) (posterior)	0.000	0.993	0.007
T50.4 Drugs affecting uric acid metabolism	0.007	0.993	0.000
Z13.7 Special screening examination for congenital malformations, deformations and chromosomal abnormalities	0.000	0.993	0.007
C11 Malignant neoplasm of nasopharynx	0.000	0.993	0.007
T50.6 Antidotes and chelating agents, not elsewhere classified	0.007	0.993	0.000
M84.1 Nonunion of fracture [pseudarthrosis]	0.007	0.993	0.000
T50.7 Analeptics and opioid receptor antagonists	0.007	0.993	0.000
T50.5 Appetite depressants	0.007	0.993	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.007	0.993	0.000
T50.0 Mineralocorticoids and their antagonists	0.007	0.993	0.000
Z13.4 Special screening examination for certain developmental disorders in childhood	0.000	0.993	0.007
C03.1 Lower gum	0.000	0.993	0.007
T50.1 Loop [high-ceiling] diuretics	0.007	0.993	0.000
Z13.8 Special screening examination for other specified diseases and disorders	0.000	0.993	0.007
T36 Poisoning by systemic antibiotics	0.007	0.993	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.000	0.993	0.006
C06.1 Vestibule of mouth	0.000	0.993	0.006
T50.8 Diagnostic agents	0.006	0.993	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.006	0.993	0.000
C05 Malignant neoplasm of palate	0.000	0.994	0.006
C04.9 Floor of mouth, unspecified	0.000	0.994	0.006
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.006	0.994	0.000
C09.8 Overlapping lesion of tonsil	0.000	0.994	0.006
C03.9 Gum, unspecified	0.000	0.994	0.006
C03.0 Upper gum	0.000	0.994	0.006
C06.0 Cheek mucosa	0.000	0.994	0.006
T46 Poisoning by agents primarily affecting the cardiovascular system	0.006	0.994	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.006	0.994	0.000
C09.0 Tonsillar fossa	0.000	0.994	0.006
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.006	0.994	0.000
C13.9 Hypopharynx, unspecified	0.000	0.994	0.006
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.006	0.994	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.006	0.994	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.006	0.994	0.000
Z13.5 Special screening examination for eye and ear disorders	0.000	0.994	0.006
C04.8 Overlapping lesion of floor of mouth	0.000	0.994	0.006
C04.1 Lateral floor of mouth	0.000	0.994	0.006
M84.18 Nonunion of fracture [pseudarthrosis] (Other)	0.006	0.994	0.000
C09.9 Tonsil, unspecified	0.000	0.994	0.006
C13.8 Overlapping lesion of hypopharynx	0.000	0.994	0.006
C13.2 Posterior wall of hypopharynx	0.000	0.994	0.006
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.000	0.994	0.006
C13.0 Postcricoid region	0.000	0.994	0.006
C10.9 Oropharynx, unspecified	0.000	0.994	0.006
C10.8 Overlapping lesion of oropharynx	0.000	0.994	0.006
C10.4 Branchial cleft	0.000	0.994	0.006
C10.3 Posterior wall of oropharynx	0.000	0.994	0.006
C10.2 Lateral wall of oropharynx	0.000	0.994	0.006
C10.1 Anterior surface of epiglottis	0.000	0.994	0.006
C10.0 Vallecula	0.000	0.994	0.006
C08.8 Overlapping lesion of major salivary glands	0.000	0.994	0.005
C08.1 Sublingual gland	0.000	0.994	0.005
C00.9 Lip, unspecified	0.000	0.994	0.005
C08.0 Submandibular gland	0.000	0.994	0.005
C00.8 Overlapping lesion of lip	0.000	0.994	0.005
C00.6 Commissure of lip	0.000	0.994	0.005
C00.5 Lip, unspecified, inner aspect	0.000	0.994	0.005
C00.4 Lower lip, inner aspect	0.000	0.994	0.005
C00.3 Upper lip, inner aspect	0.000	0.994	0.005
C00.2 External lip, unspecified	0.000	0.994	0.005
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)	0.006	0.994	0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.000	0.994	0.005
C08.9 Major salivary gland, unspecified	0.000	0.994	0.005
C00.1 External lower lip	0.000	0.994	0.005
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.005	0.994	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.006	0.994	0.000
C00.0 External upper lip	0.000	0.994	0.005
C14.2 Waldeyer's ring	0.000	0.994	0.005
T38.1 Thyroid hormones and substitutes	0.005	0.994	0.000
T40.6 Other and unspecified narcotics	0.005	0.995	0.000
Z13.2 Special screening examination for nutritional disorders	0.000	0.995	0.005
C04.0 Anterior floor of mouth	0.000	0.995	0.005
T36.0 Penicillins	0.005	0.995	0.000
Z13.3 Special screening examination for mental and behavioural disorders	0.000	0.995	0.005
C11.8 Overlapping lesion of nasopharynx	0.000	0.995	0.005
C11.3 Anterior wall of nasopharynx	0.000	0.995	0.005
C11.2 Lateral wall of nasopharynx	0.000	0.995	0.005
C11.0 Superior wall of nasopharynx	0.000	0.995	0.005
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.005	0.995	0.000
T36.4 Tetracyclines	0.005	0.995	0.000
M84.19 Nonunion of fracture [pseudarthrosis] (Site unspecified)	0.005	0.995	0.000
M84.10 Nonunion of fracture [pseudarthrosis] (Multiple sites)	0.005	0.995	0.000
T36.3 Macrolides	0.005	0.995	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.005	0.995	0.000
M43.16 Spondylolisthesis (Lumbar region)	0.005	0.995	0.000
C11.9 Nasopharynx, unspecified	0.000	0.995	0.005
T37.8 Other specified systemic anti-infectives and antiparasitics	0.005	0.995	0.000
H80.9 Otosclerosis, unspecified	0.005	0.995	0.000
F22 Persistent delusional disorders	0.005	0.995	0.000
F23 Acute and transient psychotic disorders	0.005	0.995	0.000
Z13.83 Encounter for screening for respiratory disorder NEC	0.000	0.995	0.005
M84.14 Nonunion of fracture [pseudarthrosis] (Hand)	0.005	0.995	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.005	0.995	0.000
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)	0.005	0.995	0.000
C14.0 Pharynx, unspecified	0.000	0.995	0.005
T36.9 Systemic antibiotic, unspecified	0.005	0.995	0.000
T36.7 Antifungal antibiotics, systemically used	0.005	0.995	0.000
T36.6 Rifamycins	0.005	0.995	0.000
T36.5 Aminoglycosides	0.005	0.995	0.000
T36.2 Chloramphenicol group	0.005	0.995	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.005	0.995	0.000
C34 Malignant neoplasm of bronchus and lung	0.000	0.995	0.005
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.005	0.995	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
R01 Cardiac murmurs and other cardiac sounds	0.005	0.995	0.000
M84.13 Nonunion of fracture [pseudarthrosis] (Forearm)	0.005	0.995	0.000
Z13.82 Encounter for screening for musculoskeletal disorder	0.000	0.995	0.005
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.005	0.995	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.005	0.995	0.000
C11.1 Posterior wall of nasopharynx	0.000	0.995	0.005
T36.8 Other systemic antibiotics	0.005	0.995	0.000
Z43.6 Attention to other artificial openings of urinary tract	0.000	0.995	0.005
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.995	0.000
T47.4 Other laxatives	0.005	0.995	0.000
T45.4 Iron and its compounds	0.005	0.995	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.005	0.995	0.000
C05.9 Palate, unspecified	0.000	0.995	0.005
C05.8 Overlapping lesion of palate	0.000	0.995	0.005
C05.2 Uvula	0.000	0.995	0.005
F23.9 Acute and transient psychotic disorder, unspecified	0.005	0.995	0.000
T38.9 Other and unspecified hormone antagonists	0.005	0.995	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.005	0.995	0.000
T38.7 Androgens and anabolic congeners	0.005	0.995	0.000
T38.5 Other oestrogens and progestogens	0.005	0.995	0.000
T38.4 Oral contraceptives	0.005	0.995	0.000
T38.2 Antithyroid drugs	0.005	0.995	0.000
F22.0 Delusional disorder	0.005	0.995	0.000
T46.1 Calcium-channel blockers	0.005	0.995	0.000
T38.0 Glucocorticoids and synthetic analogues	0.005	0.995	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
M43.1 Spondylolisthesis	0.005	0.995	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.005	0.995	0.000
T46.7 Peripheral vasodilators	0.005	0.995	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.995	0.000
T37.5 Antiviral drugs	0.004	0.995	0.000
T37.4 Anthelminthics	0.004	0.995	0.000
T37.3 Other antiprotozoal drugs	0.004	0.995	0.000
T37.1 Antimycobacterial drugs	0.004	0.995	0.000
T37.0 Sulphonamides	0.004	0.995	0.000
K50.0 Crohn's disease of small intestine	0.000	0.995	0.005
F21 Schizotypal disorder	0.005	0.995	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.995	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.004	0.995	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.004	0.995	0.000
T47.7 Emetics	0.004	0.995	0.000
T47.5 Digestants	0.004	0.995	0.000
T47.3 Saline and osmotic laxatives	0.004	0.995	0.000
T47.2 Stimulant laxatives	0.004	0.995	0.000
T41.5 Therapeutic gases	0.004	0.995	0.000
T41.4 Anaesthetic, unspecified	0.004	0.995	0.000
T41.3 Local anaesthetics	0.004	0.995	0.000
T41.2 Other and unspecified general anaesthetics	0.004	0.995	0.000
T41.1 Intravenous anaesthetics	0.004	0.995	0.000
T41.0 Inhaled anaesthetics	0.004	0.995	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.995	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.995	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.995	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.995	0.000
T45.5 Anticoagulants	0.004	0.995	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.995	0.000
T49.9 Topical agent, unspecified	0.004	0.995	0.000
T49.8 Other topical agents	0.004	0.995	0.000
T49.7 Dental drugs, topically applied	0.004	0.995	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.004	0.995	0.000
T49.5 Ophthalmological drugs and preparations	0.004	0.995	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.995	0.000
T49.3 Emollients, demulcents and protectants	0.004	0.995	0.000
T49.2 Local astringents and local detergents	0.004	0.995	0.000
T49.1 Antipruritics	0.004	0.995	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.995	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.995	0.000
C34.3 Lower lobe, bronchus or lung	0.000	0.996	0.004
H81.1 Benign paroxysmal vertigo	0.004	0.996	0.000
C34.0 Main bronchus	0.000	0.996	0.004
F28 Other nonorganic psychotic disorders	0.004	0.996	0.000
F24 Induced delusional disorder	0.004	0.996	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.996	0.000
T48.4 Expectorants	0.004	0.996	0.000
T48.3 Antitussives	0.004	0.996	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.004	0.996	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.996	0.000
T48.0 Oxytocic drugs	0.004	0.996	0.000
C05.1 Soft palate	0.000	0.996	0.004
T37.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
C05.0 Hard palate	0.000	0.996	0.004
T47.6 Antidiarrhoeal drugs	0.004	0.996	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.004	0.996	0.000
C34.2 Middle lobe, bronchus or lung	0.000	0.996	0.004
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.004	0.996	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.004	0.996	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.004	0.996	0.000
T40.5 Cocaine	0.004	0.996	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.004	0.996	0.000
T40.8 Lysergide [LSD]	0.004	0.996	0.000
T40.7 Cannabis (derivatives)	0.004	0.996	0.000
T40.0 Opium	0.004	0.996	0.000
F23.8 Other acute and transient psychotic disorders	0.004	0.996	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.004	0.996	0.000
T48.5 Anti-common-cold drugs	0.004	0.996	0.000
M43.12 Spondylolisthesis (Cervical region)	0.004	0.996	0.000
N76.3 Subacute and chronic vulvitis	0.000	0.996	0.004
F25 Schizoaffective disorders	0.004	0.996	0.000
F20 Schizophrenia	0.004	0.996	0.000
M43.17 Spondylolisthesis (Lumbosacral region)	0.004	0.996	0.000
T40.3 Methadone	0.004	0.996	0.000
Z43 Attention to artificial openings	0.000	0.996	0.004
T43.9 Psychotropic drug, unspecified	0.004	0.996	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.004	0.996	0.000
T40.4 Other synthetic narcotics	0.004	0.996	0.000
F22.8 Other persistent delusional disorders	0.004	0.996	0.000
F22.9 Persistent delusional disorder, unspecified	0.004	0.996	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.004	0.996	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.004	0.996	0.000
C34.8 Overlapping lesion of bronchus and lung	0.000	0.996	0.004
M43.19 Spondylolisthesis (Site unspecified)	0.004	0.996	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
R01.2 Other cardiac sounds	0.004	0.996	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.996	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.004	0.996	0.000
T43.6 Psychostimulants with abuse potential	0.004	0.996	0.000
N76.6 Ulceration of vulva	0.000	0.996	0.004
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.004	0.996	0.000
F25.2 Schizoaffective disorder, mixed type	0.004	0.996	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.996	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.996	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.996	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.996	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.003	0.996	0.000
T44.0 Anticholinesterase agents	0.003	0.996	0.000
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)	0.003	0.996	0.000
M43.15 Spondylolisthesis (Thoracolumbar region)	0.003	0.996	0.000
M43.14 Spondylolisthesis (Thoracic region)	0.003	0.996	0.000
M43.13 Spondylolisthesis (Cervicothoracic region)	0.003	0.996	0.000
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)	0.003	0.996	0.000
Z13.1 Special screening examination for diabetes mellitus	0.000	0.996	0.003
M84.11 Nonunion of fracture [pseudarthrosis] (Shoulder region)	0.003	0.996	0.000
T40.1 Heroin	0.003	0.996	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.996	0.000
M43.10 Spondylolisthesis (Multiple sites in spine)	0.003	0.996	0.000
I20.8 Other forms of angina pectoris	0.000	0.996	0.004
H80 Otosclerosis	0.003	0.996	0.000
F20.8 Other schizophrenia	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
F25.9 Schizoaffective disorder, unspecified	0.003	0.997	0.000
R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation	0.000	0.997	0.003
Z43.0 Attention to tracheostomy	0.000	0.997	0.003
N76.0 Acute vaginitis	0.000	0.997	0.003
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.003	0.997	0.000
Z43.3 Attention to colostomy	0.000	0.997	0.003
F20.2 Catatonic schizophrenia	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
I72.8 Aneurysm of other specified arteries	0.003	0.997	0.000
M43 Other deforming dorsopathies	0.003	0.997	0.000
D68.0 Von Willebrand's disease	0.000	0.997	0.003
I72.4 Aneurysm of artery of lower extremity	0.003	0.997	0.000
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.003	0.997	0.000
F20.6 Simple schizophrenia	0.003	0.997	0.000
F20.4 Postschizophrenic depression	0.003	0.997	0.000
F20.3 Undifferentiated schizophrenia	0.003	0.997	0.000
F20.1 Hebephrenic schizophrenia	0.003	0.997	0.000
F25.8 Other schizoaffective disorders	0.003	0.997	0.000
T39.0 Salicylates	0.003	0.997	0.000
Z43.9 Attention to unspecified artificial opening	0.000	0.997	0.003
Z43.7 Attention to artificial vagina	0.000	0.997	0.003
K50.8 Other Crohn's disease	0.000	0.997	0.003
M84.2 Delayed union of fracture	0.003	0.997	0.000
N76 Other inflammation of vagina and vulva	0.000	0.997	0.003
I72 Other aneurysm	0.003	0.997	0.000
D68.5 Primary Thrombophilia	0.000	0.997	0.003
R01.0 Benign and innocent cardiac murmurs	0.003	0.997	0.000
M84 Disorders of continuity of bone	0.003	0.997	0.000
F20.9 Schizophrenia, unspecified	0.003	0.997	0.000
K31.9 Disease of stomach and duodenum, unspecified	0.000	0.997	0.003
K50 Crohn's disease [regional enteritis]	0.000	0.997	0.003
F20.0 Paranoid schizophrenia	0.003	0.997	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.000	0.997	0.003
X23.9 Unspecified place	0.003	0.997	0.000
M43.8 Other specified deforming dorsopathies	0.003	0.997	0.000
M43.0 Spondylolysis	0.003	0.997	0.000
R07.1 Chest pain on breathing	0.003	0.997	0.000
Y60.0 During surgical operation	0.000	0.997	0.003
H80.0 Otosclerosis involving oval window, nonobliterative	0.003	0.997	0.000
I72.1 Aneurysm of artery of upper extremity	0.003	0.997	0.000
M84.26 Delayed union of fracture (Lower leg)	0.003	0.997	0.000
S70.9 Superficial injury of hip and thigh, unspecified	0.000	0.997	0.003
H80.8 Other otosclerosis	0.003	0.997	0.000
H80.2 Cochlear otosclerosis	0.003	0.997	0.000
H80.1 Otosclerosis involving oval window, obliterative	0.003	0.997	0.000
I72.0 Aneurysm of carotid artery	0.003	0.997	0.000
F20.5 Residual schizophrenia	0.003	0.997	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.000	0.997	0.003
Z43.2 Attention to ileostomy	0.000	0.997	0.003
M84.25 Delayed union of fracture (Pelvic region and thigh)	0.003	0.997	0.000
M84.22 Delayed union of fracture (Upper arm)	0.003	0.997	0.000
F25.1 Schizoaffective disorder, depressive type	0.002	0.997	0.000
I72.9 Aneurysm of unspecified site	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
M43.09 Spondylolysis (Site unspecified)	0.003	0.997	0.000
M43.86 Other specified deforming dorsopathies (Lumbar region)	0.002	0.997	0.000
M84.21 Delayed union of fracture (Shoulder region)	0.003	0.997	0.000
M43.9 Deforming dorsopathy, unspecified	0.003	0.997	0.000
M43.5 Other recurrent vertebral subluxation	0.002	0.997	0.000
M43.4 Other recurrent atlantoaxial subluxation	0.002	0.997	0.000
M43.3 Recurrent atlantoaxial subluxation with myelopathy	0.002	0.997	0.000
M84.27 Delayed union of fracture (Ankle and foot)	0.002	0.997	0.000
N76.4 Abscess of vulva	0.000	0.997	0.003
I72.5 Aneurysm and dissection of other precerebral arteries	0.002	0.997	0.000
D68.8 Other specified coagulation defects	0.000	0.997	0.003
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.002	0.997	0.000
D68 Other coagulation defects	0.000	0.997	0.003
M43.08 Spondylolysis (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M84.29 Delayed union of fracture (Site unspecified)	0.002	0.997	0.000
M84.28 Delayed union of fracture (Other)	0.002	0.997	0.000
M84.24 Delayed union of fracture (Hand)	0.002	0.997	0.000
M84.23 Delayed union of fracture (Forearm)	0.002	0.997	0.000
M84.20 Delayed union of fracture (Multiple sites)	0.002	0.997	0.000
M84.4 Pathological fracture, not elsewhere classified	0.002	0.997	0.000
N76.1 Subacute and chronic vaginitis	0.000	0.997	0.002
M43.06 Spondylolysis (Lumbar region)	0.002	0.998	0.000
X41.9 Unspecified place	0.002	0.998	0.000
Z43.4 Attention to other artificial openings of digestive tract	0.000	0.998	0.002
C38 Malignant neoplasm of heart, mediastinum and pleura	0.000	0.998	0.002
I72.6 Aneurysm and dissection of vertebral artery	0.002	0.998	0.000
M43.6 Torticollis	0.002	0.998	0.000
M43.2 Other fusion of spine	0.002	0.998	0.000
H81 Disorders of vestibular function	0.002	0.998	0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.000	0.998	0.002
M84.8 Other disorders of continuity of bone	0.002	0.998	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
M84.9 Disorder of continuity of bone, unspecified	0.002	0.998	0.000
N89.5 Stricture and atresia of vagina	0.000	0.998	0.002
D68.6 Other Thrombophilia	0.000	0.998	0.002
I80.8 Phlebitis and thrombophlebitis of other sites	0.000	0.998	0.002
J42 Unspecified chronic bronchitis	0.002	0.998	0.000
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)	0.002	0.998	0.000
F25.0 Schizoaffective disorder, manic type	0.002	0.998	0.001
C33 Malignant neoplasm of trachea	0.000	0.998	0.002
C78.2 Secondary malignant neoplasm of pleura	0.000	0.998	0.002
T43.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
M43.89 Other specified deforming dorsopathies (Site unspecified)	0.002	0.998	0.000
M43.88 Other specified deforming dorsopathies (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M43.87 Other specified deforming dorsopathies (Lumbosacral region)	0.002	0.998	0.000
M43.85 Other specified deforming dorsopathies (Thoracolumbar region)	0.002	0.998	0.000
M43.84 Other specified deforming dorsopathies (Thoracic region)	0.002	0.998	0.000
M43.83 Other specified deforming dorsopathies (Cervicothoracic region)	0.002	0.998	0.000
M43.82 Other specified deforming dorsopathies (Cervical region)	0.002	0.998	0.000
M43.81 Other specified deforming dorsopathies (Occipito-atlanto-axial region)	0.002	0.998	0.000
M43.80 Other specified deforming dorsopathies (Multiple sites in spine)	0.002	0.998	0.000
M43.05 Spondylolysis (Thoracolumbar region)	0.002	0.998	0.000
M43.04 Spondylolysis (Thoracic region)	0.002	0.998	0.000
M43.03 Spondylolysis (Cervicothoracic region)	0.002	0.998	0.000
M43.01 Spondylolysis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M43.00 Spondylolysis (Multiple sites in spine)	0.002	0.998	0.000
H61.2 Impacted cerumen	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.002	0.998	0.000
C38.3 Mediastinum, part unspecified	0.000	0.998	0.002
G58.9 Mononeuropathy, unspecified	0.002	0.998	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.000	0.998	0.002
K50.9 Crohn's disease, unspecified	0.000	0.998	0.002
M84.87 Other disorders of continuity of bone (Ankle and foot)	0.002	0.998	0.000
I72.2 Aneurysm of renal artery	0.002	0.998	0.000
K11.2 Sialoadenitis	0.000	0.998	0.002
C37 Malignant neoplasm of thymus	0.000	0.998	0.002
M41.86 Other forms of scoliosis (Lumbar region)	0.002	0.998	0.000
I72.3 Aneurysm of iliac artery	0.002	0.998	0.000
Z43.8 Attention to other artificial openings	0.000	0.998	0.002
Z43.5 Attention to cyctostomy	0.000	0.998	0.002
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.000	0.998	0.002
G31.8 Other specified degenerative diseases of nervous system	0.000	0.998	0.002
M43.07 Spondylolysis (Lumbosacral region)	0.002	0.998	0.000
M43.29 Other fusion of spine (Site unspecified)	0.002	0.998	0.000
M84.41 Pathological fracture, not elsewhere classified (Shoulder region)	0.002	0.998	0.000
L57.4 Cutis laxa senilis	0.002	0.998	0.000
M43.99 Deforming dorsopathy, unspecified (Site unspecified)	0.002	0.998	0.000
M84.45 Pathological fracture, not elsewhere classified (Pelvic region and thigh)	0.002	0.998	0.000
T63.4 Venom of other arthropods	0.002	0.998	0.000
M43.69 Torticollis-Site unspe	0.002	0.998	0.000
M43.98 Deforming dorsopathy, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M43.97 Deforming dorsopathy, unspecified (Lumbosacral region)	0.002	0.998	0.000
M43.96 Deforming dorsopathy, unspecified (Lumbar region)	0.002	0.998	0.000
M43.95 Deforming dorsopathy, unspecified (Thoracolumbar region)	0.002	0.998	0.000
M43.94 Deforming dorsopathy, unspecified (Thoracic region)	0.002	0.998	0.000
M43.93 Deforming dorsopathy, unspecified (Cervicothoracic region)	0.002	0.998	0.000
M43.92 Deforming dorsopathy, unspecified (Cervical region)	0.002	0.998	0.000
M43.91 Deforming dorsopathy, unspecified (Occipito-atlanto-axial region)	0.002	0.998	0.000
M43.90 Deforming dorsopathy, unspecified (Multiple sites in spine)	0.002	0.998	0.000
M84.3 Stress fracture, not elsewhere classified	0.002	0.998	0.000
C31 Malignant neoplasm of accessory sinuses	0.000	0.998	0.002
X23 Contact with hornets, wasps and bees	0.002	0.998	0.000
C18.2 Ascending colon	0.000	0.998	0.002
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.002	0.998	0.000
H80-H83 Diseases of inner ear	0.002	0.998	0.000
M43.39 Recurrent atlantoaxial subluxation with myelopathy (Site unspecified)	0.002	0.998	0.000
M43.38 Recurrent atlantoaxial subluxation with myelopathy (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M43.37 Recurrent atlantoaxial subluxation with myelopathy (Lumbosacral region)	0.002	0.998	0.000
M43.36 Recurrent atlantoaxial subluxation with myelopathy (Lumbar region)	0.002	0.998	0.000
M43.35 Recurrent atlantoaxial subluxation with myelopathy (Thoracolumbar region)	0.002	0.998	0.000
M43.34 Recurrent atlantoaxial subluxation with myelopathy (Thoracic region)	0.002	0.998	0.000
M43.33 Recurrent atlantoaxial subluxation with myelopathy (Cervicothoracic region)	0.002	0.998	0.000
M43.32 Recurrent atlantoaxial subluxation with myelopathy (Cervical region)	0.002	0.998	0.000
M43.31 Recurrent atlantoaxial subluxation with myelopathy (Occipito-atlanto-axial region)	0.002	0.998	0.000
M43.30 Recurrent atlantoaxial subluxation with myelopathy (Multiple sites in spine)	0.002	0.998	0.000
M43.49 Other recurrent atlantoaxial subluxation-Site unspe	0.002	0.998	0.000
M43.48 Other recurrent atlantoaxial subluxation-Sacral/sacrococ	0.002	0.998	0.000
M43.47 Other recurrent atlantoaxial subluxation-Lumbosacral	0.002	0.998	0.000
M43.46 Other recurrent atlantoaxial subluxation-Lumbar	0.002	0.998	0.000
M43.45 Other recurrent atlantoaxial subluxation-Thoracolumbar	0.002	0.998	0.000
M43.44 Other recurrent atlantoaxial subluxation-Thoracic	0.002	0.998	0.000
M43.43 Other recurrent atlantoaxial subluxation-Cervicothoracic	0.002	0.998	0.000
M43.42 Other recurrent atlantoaxial subluxation-Cervical	0.002	0.998	0.000
M43.41 Other recurrent atlantoaxial subluxation-Occipit-atl-axl	0.002	0.998	0.000
M43.40 Other recurrent atlantoaxial subluxation-Mult site	0.002	0.998	0.000
M43.59 Other recurrent vertebral subluxation (Site unspecified)	0.002	0.998	0.000
M43.58 Other recurrent vertebral subluxation (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M43.57 Other recurrent vertebral subluxation (Lumbosacral region)	0.002	0.998	0.000
M43.56 Other recurrent vertebral subluxation (Lumbar region)	0.002	0.998	0.000
M43.55 Other recurrent vertebral subluxation (Thoracolumbar region)	0.002	0.998	0.000
M43.54 Other recurrent vertebral subluxation (Thoracic region)	0.002	0.998	0.000
M43.53 Other recurrent vertebral subluxation (Cervicothoracic region)	0.002	0.998	0.000
M43.52 Other recurrent vertebral subluxation (Cervical region)	0.002	0.998	0.000
M43.51 Other recurrent vertebral subluxation-Occipit-atl-axl	0.002	0.998	0.000
M43.50 Other recurrent vertebral subluxation (Multiple sites in spine)	0.002	0.998	0.000
R46.2 Strange and inexplicable behaviour	0.000	0.998	0.002
T23.3 Burn of third degree of wrist and hand	0.000	0.998	0.002
N18.0 End-stage renal disease	0.002	0.998	0.000
T24.3 Burn of third degree of hip and lower limb, except ankle and foot	0.000	0.998	0.002
C38.4 Pleura	0.000	0.998	0.002
M84.49 Pathological fracture, not elsewhere classified (Site unspecified)	0.002	0.998	0.000
M84.47 Pathological fracture, not elsewhere classified (Ankle and foot)	0.002	0.998	0.000
M84.46 Pathological fracture, not elsewhere classified (Lower leg)	0.002	0.998	0.000
M84.44 Pathological fracture, not elsewhere classified (Hand)	0.002	0.998	0.000
M84.43 Pathological fracture, not elsewhere classified (Forearm)	0.002	0.998	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.000	0.998	0.002
C38.2 Posterior mediastinum	0.000	0.998	0.002
C38.1 Anterior mediastinum	0.000	0.998	0.002
C38.0 Heart	0.000	0.998	0.002
X23.0 Home	0.002	0.998	0.000
M43.28 Other fusion of spine (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M43.25 Other fusion of spine (Thoracolumbar region)	0.002	0.998	0.000
M43.24 Other fusion of spine (Thoracic region)	0.002	0.998	0.000
M43.23 Other fusion of spine (Cervicothoracic region)	0.002	0.998	0.000
M43.21 Other fusion of spine (Occipito-atlanto-axial region)	0.002	0.998	0.000
M43.20 Other fusion of spine (Multiple sites in spine)	0.002	0.998	0.000
M43.68 Torticollis-Sacral/sacrococ	0.002	0.998	0.000
M43.67 Torticollis-Lumbosacral	0.002	0.998	0.000
M43.66 Torticollis-Lumbar	0.002	0.998	0.000
M43.65 Torticollis-Thoracolumbar	0.002	0.998	0.000
M43.64 Torticollis-Thoracic	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations